China Microrna Market Size & Outlook, 2023-2030
China microrna market, 2018-2030 (US$M)
Related Markets
China microrna market highlights
- The China microrna market generated a revenue of USD 80.9 million in 2023 and is expected to reach USD 218.9 million by 2030.
- The China market is expected to grow at a CAGR of 15.3% from 2024 to 2030.
- In terms of segment, services was the largest revenue generating services scope in 2023.
- Services is the most lucrative services scope segment registering the fastest growth during the forecast period.
Microrna market data book summary
| Market revenue in 2023 | USD 80.9 million |
| Market revenue in 2030 | USD 218.9 million |
| Growth rate | 15.3% (CAGR from 2023 to 2030) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Products Type |
| Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Horizon Discovery, NanoString Technologies, Merck KGaA, Takara Bio Inc, LGC Group, Biogenex, New England Biolabs, GeneCopoeia |
Other key industry trends
- In terms of revenue, China accounted for 5.1% of the global microrna market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China microrna market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 218.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
MicroRNA Market Scope
MicroRNA Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China microrna market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microrna market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 58.71% in 2023. Horizon Databook has segmented the China microrna market based on services, products type covering the revenue growth of each sub-segment from 2018 to 2030.
China's life sciences and pharmaceutical industry has grown at a lucrative rate in recent years. The country is projected to lead in Asia's genomics space. Increasing focus on precision medicine and the high potential of miRNAs in developing precision medicine are expected to positively influence market growth.
Furthermore, organizations such as the National Science Foundation and the National Nature Science Foundation provide funding and support various omics research. These organizations encourage collaboration of the country's traditional knowledge with scientific advances.
For instance, studies are being conducted to investigate the role of miRNAs and Chinese alternative and complementary medicines, such as herbs. Additionally, in September 2019, researchers from the Chinese Academy of Sciences (Suzhou Institute of Biomedical Engineering and Technology) developed a new method for detecting miRNAs using chameleon silver nanoclusters and hybridization chain reactions.
Reasons to subscribe to China microrna market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China microrna market databook
-
Our clientele includes a mix of microrna market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China microrna market , including forecasts for subscribers. This country databook contains high-level insights into China microrna market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China microrna market size, by services scope, 2018-2030 (US$M)
China MicroRNA Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
